nDatalyze Corp. updates the "Epitome" Predictive Sports Performance Analytics Project and the RTO progress

Group 1 - nDatalyze Corp. has announced that its sports analytics predictive scoring formulas, including genetic markers, are currently in testing and calibration [1] - The Epitome online questionnaire is now live and also undergoing testing, with data collection from three junior league teams expected to start in mid-October and conclude by year-end 2025 [1] - Machine learning has played a crucial role in the development of Epitome, significantly reducing costs and accelerating development time [1] Group 2 - The ongoing reverse takeover (RTO) process is in progress, with the controlling shareholder awaiting a tax opinion before finalizing the private placement amount [2] - Trading of the Corporation's shares will remain halted until the RTO is either completed or abandoned [2]